Introduction
Alterations in membrane-trafficking patterns can radically affect the maintenance of polarity in differentiated epithelial cells, and a loss of polarity is thought to play a critical role in the early pathogenesis of neoplasia (1, 2) . Rab small GTPases are involved in the full gamut of vesicle-trafficking pathways within cells (3, 4) . In particular, the Rab11 family members, consisting of Rab11a, Rab11b, and Rab25, regulate various aspects of membrane recycling and trafficking to the plasma membrane (5, 6) . Rab25 is enriched in epithelial cells (5) . Prominent expression of Rab25 has been observed throughout the gastrointestinal mucosa, with the highest expression seen in ileum and colon. High levels of expression are also present in the lung and kidney, with a very minor and variable level of expression in splenic tissue. No expression of Rab25 has been seen in the brain, heart, liver, skeletal muscle, or the gastric wall (5) . Recent investigations have suggested that Rab25 expression can alter breast and ovarian tumor cell-line behavior. Cheng et al. (7) noted that MCF-7 breast carcinoma cells exhibited more aggressive properties following overexpression of Rab25. In contrast, Rao and colleagues (8) have suggested that loss of Rab25 in breast cancer cell lines lacking estrogen and progesterone receptors leads to more aggressive behavior. It seems likely that some of these divergent findings may result from regulation of pathways dictating the trafficking of specific cargoes. Recent studies have indicated that, in an ovarian cancer cell line, Rab25 associates with and regulates the trafficking of α 5 β 1 integrin and that this can alter tumor cell invasion in vitro (9) .
Current models for colorectal adenocarcinoma implicate serial genetic alterations within the colonic epithelium as the basis of cancer formation. Based on its genetic origin, colon cancer can be divided into 2 classes, polyposis colon cancer and nonpolyposis colon cancer. Genes whose mutations are responsible for colon carcinogenesis have been discovered through molecular genetic studies of hereditary cancer predisposition syndromes such as familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) (10, 11) . Individuals with FAP develop numerous benign colorectal polyps due to a germline mutation in the adenomatous polyposis coli (APC) gene, which was identified on chromosome 5q as one of the genes commonly deleted in FAP kindreds (12, 13) . The first mouse mutant in the Apc gene (the mouse homolog of human APC on mouse chromosome 18) was identified from a colony of randomly mutagenized mice (14) . This mutant, multiple intestinal neoplasia (Min) carried a truncation mutation at codon 850 of the Apc gene; hence the designation of Apc Min (15) . All Apc mutant mice develop adenomatous polyps in the small intestine and with lower frequency also in the colon, but tumors rarely progress to adenocarcinoma. If additional mutations are introduced into these mice, however, these additional genetic events can lead to development of more advanced tumors (16, 17) . HNPCC is caused by mutations in the genes that encode the enzymatic machinery for mismatch repair (18) . One locus that is mutated in HNPCC encodes the type II receptor for TGF-β (19) . A commonly mutated pathway in colon cancer exhibiting microsatellite instability is the TGF-β pathway. The SMAD proteins are downstream effectors of the TGF-β signaling pathway. As a progressive model of colon cancer, all of the Smad3 -/-mice on the 129/Sv background develop proximal and/or distal colonic tumors by 6 months of age (20) .
We have sought to determine the effects of loss of Rab25, an epithelial-specific small GTPase, on the evolution of colonic neoplasia. We have observed that Rab25 expression is significantly lower in human colon cancers independent of stage and lower Rab25 expression predicts poorer survival. In mice, targeted disruption of Rab25 expression promotes intestinal neoplasia in 2 different pathway models of either intestinal polyposis or colon carcinogenesis. We also have shown that loss of Rab25 in the intestine leads to a reduction in basolateral presentation of β 1 integrin in intestinal villi and correlates with the promotion of polyp formation. Taken together, all of this work supports a role of Rab25 as a tumor suppressor in intestinal mucosae.
Results

Rab25 gene expression in human colon cancer.
Given the findings in breast cancer specimens, which suggested that Rab25 levels were altered in breast cancer, we interrogated an established database of gene-expression profiles for human colon cancers (21) . Gene expression was assessed for Rab25 using the Affymetrix 218186 probe set. Expression of Rab25 was significantly decreased in colon adenocarcinomas compared with normal colon (P < 0.03) independent of Duke's stage. Rab25 expression was also reduced in LN metastases as well as in liver and lung metastases ( Figure  1A) . Moreover, we also compared overall survival in colon cancer patients according to expression of Rab25. Kaplan-Meier analysis was performed comparing survival in patients with Rab25 expression above the median (low risk) to those with Rab25 expression below the median (high risk). Lower expression of Rab25 correlated with significantly shorter survival (P < 0.035) ( Figure 1B ). These results suggested that Rab25 might act as a tumor suppressor in the colon.
To determine whether Rab25 was differentially expressed in an independent cohort of colorectal cancer patients, we interrogated Affymetrix gene microarray results for expression of Rab25 (probe 218186) in patients with adenomas (n = 6) and adenocarcinomas (n = 55) from Vanderbilt Medical Center (22) . The demographics for this group are listed in Supplemental Table 1 (supplemental material available online with this article; doi:10.1172/JCI40728DS1). We found that Rab25 expression was significantly lower in the adenocarcinoma group compared with adenomas ( Figure 1C ; P = 0.02). Additionally, we evaluated adenomas and individual stage groups and found significant differences in the stage I and stage IV patients when compared with adenomas ( Figure 1D ; P < 0.001 and P = 0.02) and a trend toward lower expression for the stage II and III patients ( Figure 1D ; P = 0.07 and P = 0.06, respectively).
To verify the results in gene microarray studies, we examined Rab25 expression levels in RNA from 4 normal colon samples from patients with diverticulitis compared with 10 colon adenocarcinoma patient samples by quantitative RT-PCR analysis. The colon adenocarcinoma samples spanned the range of stages, with 3 stage I, 4 stage II, 2 stage III, and 1 stage IV tumor. To quantitate differences, we calculated the efficiency-adjusted Ct values for each normal and tumor sample (see Methods). We observed significantly lower expression of Rab25 in colon tumor samples compared with normal colon samples ( Figure 2 ; P = 0.01). Taken together, these data confirmed that Rab25 expression was significantly decreased in adenocarcinomas and supported a potential tumor-suppressive role for Rab25 in colorectal cancer.
Construction and characteristics of Rab25-knockout mouse. To address directly the effects of reduced Rab25 expression on colonic neoplasia, we constructed a mouse with targeted disruption of the Rab25 gene ( Figure 3 ). Rab25-deficient mice were born in normal Mendelian ratios and did not show any significant abnormalities up to 4 months of age. Mice were bred through 12 generations of crossing to either C57BL/6 or 129/J strain backgrounds without any alterations in gross phenotype. Rab25-deficient mice did not show any detectable levels of Rab25 mRNA, and in addition, there was a complete absence of detectable Rab25 protein ( Figure 3D ).
Interestingly, we observed that heterozygous mice showed intermediate reductions in Rab25 protein expression, suggesting haploinsufficiency ( Figure 3D ). C57BL/6 background mice showed no significant anatomical or pathological abnormalities up to 1 year of age. For Rab25-deficient mice on the 129/J background only, after 10 months of age, we observed the development of vaginal cancer in virgin females and distal esophageal stricture due to squamous cell hyperplasia in both males and females (K.T. Nam, unpublished observations).
Rab25 is an epithelial-specific small GTPase (5). Therefore, as a final means to establish the efficacy of the Rab25 knockout, we compared the staining for Rab25 in intestine in wild-type versus Rab25-deficient mice. Figure 3E demonstrates that Rab25 was most strongly expressed in cells on the luminal side of the proliferative zone in intestinal crypts. Rab25 staining localized to the perinuclear region in a pattern similar to that observed previously in Barrett epithelium (23) . No staining for Rab25 was observed in the intestines of Rab25-knockout mice ( Figure 3E ).
The effects of Rab25 deficiency associated with tumor initiation in the Apc Min/+ mice. Apc Min/+ mice, which are heterozygous for mutant Apc, develop multiple polyps in the small bowel and a smaller number of polyps in the colon (24) . To assess the role of Rab25 in regulating tumorigenesis, we examined polyp formation in Apc Min/+ mice bred onto a background of Rab25 +/+ , Rab25 +/-, or Rab25 -/-. Figure 4 demonstrates that Apc Min/+ ;Rab25 -/-mice showed an increase in tumor formation throughout the intestines. We observed a significant 4-fold increase in tumor number ( Figure 4 , B and C, and Supplemental Table 2 ). Interestingly, Apc Min/+ ;Rab25 +/-mice also showed a significant increase in tumor number that was intermediate between wild-type and Rab25-deficient mice ( Figure 4B and Supplemental Table 2 ). These studies indicated that Rab25 loss promoted adenoma formation and that the effects correlated with Rab25 dosage.
We also examined the presence of colonic tumors in Apc Min/+ mice on the Rab25-deficient or heterozygous backgrounds. Figure 5 demonstrates that Apc Min/+ ;Rab25 -/-mice showed a significant 2-fold increase in colonic polyp number as well as a significant increase in polyp size ( Figure 5B and Supplemental Table 2 ). We also observed that polyps were distributed more widely in the colon in Apc Min/+ ;Rab25 -/-( Figure 5B ). The results indicate that Rab25 loss is associated with increased tumor formation in Apc Min/+ mice.
Microscopic examination of the Apc Min/+ mouse tumors in both the intestine and colon showed that the lesions were tubular adenomas, as previously noted in Apc Min/+ mice (Figures 4 and 5) . We did not observe any increase in invasive character in the adenomas in
Figure 2
Rab25 expression is lower in colon cancers compared with normal colonic mucosa. 14 patient samples (4 normal colon samples and 10 colon adenocarcinomas) were examined by quantitative RT-PCR analysis. The 1/Ct adjusted Rab25 expression values were determined for all samples. A significant reduction of Rab25 expression was observed when normal samples were compared with tumor samples (*P = 0.01; Mann-Whitney U test). All values are shown as mean ± SEM.
Apc Min/+ ;Rab25 -/-mice. Since adenoma formation in Apc Min/+ mice has been associated with loss of heterozygosity at the wild-type locus (25, 26) , we have evaluated Apc alleles in microdissected adenomas. We observed no difference in the frequency of loss of heterozygosity in Apc Min/+ ;Rab25 +/+ mice compared with Apc Min/+ ;Rab25 -/-mice (data not shown). These results indicate that loss of Rab25 does not alter induction of the loss of heterozygosity at the Apc locus.
We also examined the distribution of Rab25 in Apc Min/+ mice. Figure 6 demonstrates that Apc Min/+ mice with a wild-type Rab25 background showed decreased Rab25 immunostaining in the cells at the transition from crypt to villus ( Figure 3E vs. Figure  6 , A and E). Interestingly, we also observed ectopic expression of Rab25 in villus cells adjacent to intestinal polyps (Figure 6 , C and G). Also, we observed no staining for Rab25 in Apc Min/+ mouse intestinal adenomas and polyps ( Figure 6 , C and F). As expected, no Rab25 staining was found in Apc Min/+ mice on a Rab25-deficient background ( Figure 6, D and H) .
Rab25 deficiency and β 1 integrin localization in intestinal cells. Previous studies have linked Rab25 to the trafficking of β 1 integrin (9). Therefore, we examined the distribution of β 1 integrin in Apc Min/+ and Rab25-deficient mice (Figure 7) . In wild-type mice, β 1 integrin staining was prominently observed at the lateral membrane in villus cells, with less staining in crypt cells ( Figure 7A ). In contrast, villus cells in Rab25-deficient mice had diminished lateral staining with more prominent intracellular staining for β 1 integrin ( Figure 7B ). In Apc Min/+ mice, we noted a similar decrease in β 1 integrin staining in the lateral membranes of villus cells not immediately associated with adenoma formation as well as in the adenomas themselves ( Figure 7 , C and E). In Apc Min/+ ;Rab25 -/-mice, we observed essentially complete loss of lateral β 1 integrin staining, and staining was only detected intracellularly ( Figure 7D ). These results suggested that loss of Rab25 affected β 1 integrin localization in intestinal cells.
The effects of Rab25 deficiency associated with tumor invasion in Smad3 +/-mice. Given the striking increase in tumorigenesis observed in Apc Min/+ mice on the Rab25-deficient background, we sought to evaluate the effects of Rab25 loss in a second model associated with colon tumor invasion. Loss of Smad3 in mice is associated with development of colon tumors in the proximal colon (20) . While Smad3 -/-mice develop invasive proximal colon tumors, Smad3 heterozygotes show little if any overt pathology (20) . We therefore examined the effects of Rab25 deficiency on the colonic mucosa of Smad3 +/-mice. While Smad3 +/-mice on a Rab25 +/+ background did not show any adenomas (Figure 8, A and B) , the Smad3 +/-;Rab25 -/-mice showed large invasive lesions in 80% of animals ( Table 1) . Tumors were identified in both the proximal colonic mucosa and in the rectum. By microscopic analysis, in Smad3 +/-;Rab25 -/-mice, a spectrum of tumors was documented that ranged from aberrant or dysplastic crypts, hyperplastic lesions, and adenomatous polyps to cancerous lesions with progressive degrees of atypia and invasion ( Table 1 ). The colonic epithelial tumors often extended into and through the submucosa with neoplastic glands penetrating the muscle wall (Figure 8 , C and E, and Table 1 ). In a typical example of a more aggressive proximal tumor, the glandular atypia resulted in numerous mucin-filled cysts (Figure 8, C, D, F, and G) . In Rab25 -/-mice on the 129 background, independent of Smad3, we also observed neoplastic vaginal squamous epithelial cells invading the muscle layer ( Figure 8H ). All of these results support a role for Rab25 loss in the early promotion of colonic neoplasia.
Discussion
Rab small GTPases have been the focus of considerable investigation over the past decade as critical regulators of intracellular vesicle trafficking. It seems intuitive that membrane trafficking is likely involved in many aspects of cell biology relevant to carcinogenesis, including loss of polarity, cell invasion, and cell metastasis. However, few studies have directly addressed the role of Rab proteins in epithelial neoplasia. Nevertheless, investigations over the past several years have increasingly pointed to roles for Rab proteins and their effectors in the regulation of aspects of the establishment and maintenance of polarity (27) . The loss of polarity in epithelial cells represents a critical early event in the pathway toward neoplastic transformation (28) . Rab11a, Rab11b, and Rab25 share a number of effectors (6, 29) . While initial studies had suggested that overexpression of Rab25 potently inhibited trafficking through the apical recycling system (30) , it remains unclear whether these results were a direct effect or the result of competition for regulators shared with Rab11a, an established promoter of recycling system trafficking. Indeed, this competition between Rab11a and Rab25 for effectors could be physiologically relevant and regulate the balance between various membrane-trafficking pathways. Imbalances in trafficking could lead to alterations in membrane components that would affect critical aspects of membrane polarity.
Previous studies have noted an increase in Rab25 expression in some ovarian and breast cancers (7) . However, other studies have suggested that in estrogen receptor-negative breast cancers, loss of Rab25 actually promotes a more aggressive phenotype (8) . We have examined induction of breast cancer and metastases in MMTV- polyoma middle T-expressing mice crossed onto the Rab25-null background and observed no significant effects of Rab25 deficiency on either development of breast tumors or lung metastases (B. Fingleton and J.R. Goldenring, unpublished observations). In contrast, in the present study on intestinal neoplasia, Rab25 deficiency promoted colonic neoplasia in 2 different models of either intestinal polyposis or invasive colon cancer. These results suggest that Rab25 likely influences an early step in intestinal neoplasia. We observed that the major expression of Rab25 in the intestine was in the cells just luminal to the active progenitor cells of the crypt. These are the same cells that are thought to be involved in the development of adenomas in Apc Min/+ mice (24, 31) . It is of interest that we observed decreases in Rab25 expression in these cells in Apc Min/+ mice compared with wild-type mice. Further (32) have also demonstrated that alterations in α 5 β 1 integrin interactions can lead to increases in metastatic behavior. Thus, loss of Rab25 may promote mislocalization of integrin away from the lateral membranes, thus promoting further proneoplastic influences. Given the variety of specific cargoes expressed in different epithelial cells and the previous results in breast cancer cells, it seems likely that either Rab25 loss or Rab25 overexpression could lead to transformation, depending on the particular cargoes trafficked in individual epithelial cell populations.
The data presented here also support a role for Rab25 as an early general colonic tumor suppressor. Rab25 loss also led to a marked acceleration in invasive colon tumor formation in Smad3 +/-mice. The general phenotype of the Smad3 +/-;Rab25 -/-mice was similar to previously reported accelerated pathology in Apc Min/+ ;Smad3 -/-mice (33) . The Apc Min/+ ;Smad3 -/-mice also showed more rapid and extensive colon tumor formation. Those investigations suggested that Wnt and TGF-β receptor-mediated pathways could cooperate in regulation of tumor suppression. In the case of the studies reported here, we observed marked tumor formation in Smad3 heterozygote mice on the Rab25-deficient background. These results indicate that multiple pathways can synergize to lead to the eventual manifestation of colon tumor formation. It seems logical that disruption of aspects of polarized trafficking through the loss of Rab25 could predispose mucosal epithelial cells to secondary perturbations by either loss of Apc function or loss of Smad3, leading to accelerated transformation.
In summary, the present investigations demonstrate that loss of Rab25 leads to increased tumorigenesis in both Apc Min/+ mice and Smad3 +/-mice. Given our findings that lower Rab25 expression is associated with poorer prognosis in colon cancer patients, the present investigations suggest that reduction of Rab25 expression is associated with the initiation of colonic neoplasia. The loss of β 1 integrin staining at the lateral membrane supports a scenario in which loss of Rab25 leads to an alteration in trafficking of key cargoes regulating aspects of polarity, thus predisposing intestinal and colonic epithelial to transformation. All of these findings support a role for Rab25 as an early tumor suppressor in the intestinal mucosa. containing all 5 exons was cloned into pBluescript. The Rab25 gene was interrupted by insertion of the Neomycin resistance gene along with 3 tandem in-frame stop codons into the second exon. The resulting transgene was then linearized and injected into R1 ES cells. Cells were screened for neomycin resistance, and candidate cell lines were examined for homologous recombination by Southern blotting of EcoRV digests of genomic DNA. Two selected cell lines were injected in blastocysts, and chimeras were identified. One founder line was transmitted 100% to offspring. The founders were crossed through 12 generations to both C57BL/6 mice and 129/J mice. During the experiments, the mice were maintained with regular mouse chow and water ad libitum in a temperature-controlled room under a 12-hour light/12-hour dark cycle. The care, maintenance, and treatment of animals in these studies followed protocols approved by the Institutional Animal Care and Use Committee of Vanderbilt University.
Methods
Construction of
Southern blotting. Genomic DNA was isolated from mouse tails using a QIAGEN Genomic DNA isolation kit (QIAGEN). 2 μg of genomic DNA was digested overnight at 37°C with EcoRV. Southern blots were probed with [ 32 P]-labeled DNA probe corresponding to the unique 3′ coding sequence of murine Rab25.
PCR assay. 1 μg of genomic DNA was utilized to amplify wild-type and knockout sequences using a 3-primer reaction. Primer sequences are listed in Supplemental Table 3 .
Anti-Rab25 antibody. The rabbit polyclonal antibody was raised against a specific peptide sequence at the murine Rab25 carboxyterminal variable domain, QNSTRTSAITLGNAQAGQDPGLGEKR. KLH was covalently attached to the N terminus for immunization of the rabbits (Covance). The antiserum was affinity purified against the immunization peptide covalently coupled by the carboxyl terminus to a solid matrix (EDC/Diaminodipropylamine Immobilization kit; Pierce). Rab25 antibodies did not recognize either recombinant Rab11a or Rab11b (L. Lapierre and J.R. Goldenring, unpublished observations). Rab25 antibodies stained discrete populations of epithelial cells, including stomach, esophagus, skin, tongue, and kidney (Supplemental Figure 1) as well as cells within the intestines. 
